Ordering
Available Variants5 mg
CHJ.51126-5mg
Price
€100.00
Available – Dispatch in 14 days
25 mg
CHJ.51126-25mg
Price
€400.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHJ.51126-5mg | €100.00 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHJ.51126-25mg | €400.00 |
≥98% (HPLC), jumonji H3K27 demethylase inhibitor, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C24H27N5O2 |
|---|---|
| CAS Number | 1373423-53-0 |
| Molecular Weight | 417.50 |
| UNSPSC Code | 51111800 |
| PubChem Substance ID | 329825585 |
| NACRES | NA.77 |
| MDL number | MFCD22683852 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
| Storage condition | desiccated |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
GSK-J4, also known as CAS 1373423-53-0, is a small molecule inhibitor that has been extensively studied for its potential therapeutic applications. It is a selective inhibitor of the histone demethylase enzymes, specifically targeting the Jumonji C-domain containing proteins. By inhibiting these enzymes, GSK-J4 has been shown to modulate various cellular processes, including gene expression and cell signaling pathways. Research has demonstrated that GSK-J4 exhibits anti-inflammatory and anti-cancer properties, making it a promising candidate for the treatment of various diseases, including cancer and inflammatory disorders. Further studies are needed to fully elucidate the mechanisms of action and potential therapeutic applications of GSK-J4, but its unique inhibitory profile and biological activity make it an attractive compound for ongoing research and development in the field of pharmacology. Its potential as a therapeutic agent is being explored in various preclinical studies.
